Genetic polymorphisms related to the renin–angiotensin–aldosterone system and response to antihypertensive drugs

By Taverne Kim   de Groot Mark   de Boer Anthonius   Klungel Olaf  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 4, 2010-04 ,pp. : 439-460

Informa Healthcare

Access to resources Recommend Favorite

Drugs with Blocking Effects on the Renin–Angiotensin–Aldosterone System Do Not Improve Endothelial Dysfunction Long-term in Hypertensive Patients

By Sozen AB   Kayacan MS   Tansel T   Celebi A   Kudat H   Akkaya V   Erk O   Hatipoglu I   Demirel S  

The Journal of International Medical Research, Vol. 37, Iss. 4, 2009-07 ,pp. : 996-1002

Field House Publishing

Access to resources Recommend Favorite

Renin Angiotensin System Gene Polymorphisms in Response to Antihypertensive Drugs and Visit-To-Visit Blood Pressure Variability in Essential Hypertensive Patients

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 12, Iss. 4, 2014-12 ,pp. : 227-235

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs which target the renin–angiotensin–aldosterone system

By Steckelings Ulrike Muscha   Paulis Ludovit   Unger Thomas   Bader Michael  

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 4, 2011-12 ,pp. : 619-630

Informa Healthcare

Access to resources Recommend Favorite

Pleiotropic Effects of Drugs Inhibiting the Renin-Angiotensin-Aldosterone System

By  

Current Pharmaceutical Design, Vol. 15, Iss. 5, 2009-02 ,pp. : 571-584

Bentham Science Publishers

Access to resources Recommend Favorite